Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease (Q30519560)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease |
scientific article |
Statements
1 reference
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease (English)
1 reference
Yong Hong Chen
1 reference
Kristin Claflin
1 reference
James C Geoghegan
1 reference
Beverly L Davidson
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference